These promotions are characterised by altered news footage and baseless claims of approval from the country’s Food and Drug Administration (FDA). However, a thorough investigation reveals a stark disparity: the product in question is notably absent from the FDA’s databases. Additionally, the “license to operate” prominently featured on the product’s website can be traced back to an entirely unrelated company. These discrepancies therefore underscore the urgent need for consumers to exercise caution. Patients should also seek guidance from medical professionals when addressing thyroid-related issues.
